?

Qasi Najah1,2, Nereen A Almosilhy3,4, Thoria Ibrahim Essa Ghanm5,4

  • 1Faculty of Medicine, Elmergib University, Al-Khums, Libya. qasinajah@gmail.com.

概括

与尼沃卢马布和伊皮利穆马布的联合免疫疗法改善了肺癌患者的无进展生存率,但增加了不良事件. 证据不足以推它超过尼沃卢马布单一治疗.